Zomedica (ZOM)
(Real Time Quote from BATS)
$0.15 USD
0.00 (0.33%)
Updated Jul 25, 2024 10:08 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ZOM 0.15 0.00(0.33%)
Will ZOM be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ZOM based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for ZOM
Stifel Nicolaus Remains a Buy on ZoomInfo Technologies (ZI)
The United States Eventing Association Names Zomedica’s PulseVet(R) as the Official Shock Wave of the USEA
Wells Fargo Sticks to Their Buy Rating for ZoomInfo Technologies (ZI)
Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform
Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark